Clinical trial
Dabigatran-related Effect on Progression of Atrial Fibrosis in Patients With Atrial Fibrillation
NCT01546883 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dabigatran-related Effect on Progression of Atrial Fibrosis in Patients With Atrial Fibrillation
- Lead sponsor
- University of Utah
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- February 29, 2012
- Completion date
- December 31, 2013
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.